Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Clinical Evaluation of 3D-Printed Versus Semi-Direct Composite Resin Restorations

30. juni 2026 oppdatert av: Mohammed Abd El Ghany Mohammed, Tanta University
This randomized controlled clinical trial aims to evaluate the clinical performance of 3D-printed composite resin restorations compared with semi-direct composite resin restorations in posterior teeth requiring Class II inlay or onlay restorations.

Studieoversikt

Detaljert beskrivelse

Dental restorations are commonly used to restore teeth affected by caries or structural defects. Advances in digital dentistry have introduced three-dimensional (3D) printing technologies that enable the fabrication of indirect composite resin restorations with improved precision, efficiency, and reproducibility. Semi-direct composite resin restorations represent another conservative restorative approach that combines the advantages of direct and indirect techniques while reducing polymerization shrinkage and improving anatomical form.

Although both techniques are increasingly used in clinical practice, evidence regarding their long-term clinical performance remains limited. Therefore, this randomized controlled clinical trial aims to compare the clinical performance of 3D-printed composite resin restorations and semi-direct composite resin restorations in posterior teeth requiring Class II inlay or onlay restorations.

Sixty patients aged 25 to 40 years who require two Class II inlay or onlay restorations will be enrolled by invitation from patients attending the Faculty of Dentistry, Tanta University. Participants will be randomly allocated into two groups according to the restorative material and fabrication technique used. Group I will receive 3D-printed composite resin restorations, while Group II will receive semi-direct composite resin restorations.

All cavity preparations and restorative procedures will be performed according to standardized clinical protocols and manufacturers' instructions. Clinical evaluations will be conducted at baseline, 6 months, 9 months, and 12 months after restoration placement using the modified FDI World Dental Federation criteria.

The primary objective is to evaluate the overall clinical performance and survival of the restorations over a 12-month follow-up period. Secondary outcomes include assessment of retention, marginal integrity, surface roughness, anatomical form, postoperative sensitivity, and the occurrence of secondary caries.

The findings of this study will contribute to the evidence regarding the effectiveness and clinical reliability of 3D-printed composite resin restorations compared with semi-direct composite resin restorations and may support clinical decision-making in restorative dentistry.

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Tanta
      • Tanta, Tanta, Egypt, 31527
        • Restorative Department, Faculty of Dentistry, Tanta University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Patients aged 25-40 years.
  • Patients requiring two Class II inlay or onlay restorations.
  • Teeth with carious lesions or defective restorations requiring indirect restorative treatment.
  • Teeth with sufficient structure to receive an inlay/onlay restoration.

Exclusion Criteria:

  • Patients with systemic diseases or medical conditions that may affect oral health or healing.
  • Pregnant or lactating patients.
  • Patients with poor oral hygiene or uncontrolled periodontal disease.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: 3D-Printed Composite Resin Restorations
Participants will receive Class II inlay or onlay restorations fabricated using 3D-printed composite resin. Restorations will be placed following standardized cavity preparation and manufacturer instructions. Clinical performance will be evaluated at baseline, 6, 9, and 12 months using modified FDI criteria
Fabrication and placement of Class II inlay or onlay restorations using 3D-printed composite resin material.
Eksperimentell: Semi-Direct Composite Resin Restorations
Participants will receive Class II inlay or onlay restorations fabricated using the semi-direct composite resin technique. Restorations will be placed following standardized cavity preparation and manufacturer instructions. Clinical performance will be evaluated at baseline, 6, 9, and 12 months using modified FDI criteria
Fabrication and placement of Class II inlay or onlay restorations using the semi-direct composite resin technique

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Fracture of restorations
Tidsramme: 12 months
Clinical evaluation of restoration fracture or bulk failure after placement of 3D-printed composite resin and semi-direct composite resin restorations. at baseline, 6 months, 9 months, and 12 months after restoration placement. using a modified FDI criteria score. All restorations will be evaluated and categorized based on their clinical performance according to the assigned criteria: score 1 indicates a clinically excellent restoration, scores 2 and 3 represent clinically acceptable restorations, while scores 4 and 5 are considered clinically unacceptable. Clinical success will be defined as restorations receiving scores of 1, 2, or 3, whereas scores of 4 or 5 will be considered clinical failures.
12 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

5. januar 2026

Primær fullføring (Antatt)

28. februar 2027

Studiet fullført (Antatt)

3. mars 2027

Datoer for studieregistrering

Først innsendt

24. juni 2026

Først innsendt som oppfylte QC-kriteriene

24. juni 2026

Først lagt ut (Faktiske)

30. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

2. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere